Skip to main content
. 2020 Jul 14;10:11599. doi: 10.1038/s41598-020-68398-0

Table 2.

Biomarker levels in AKI patients

Recovery Plasma creatinine (mg/dL) Proteinuria (mg/mg Cru) Urinary NAG (IU/mg Cru) Urinary NGAL (mg/mg Cru) Urinary t-Gelsolin (AU/mg Cru) Urinary KIM-1 (AU/mg Cru) Urinary TCP1-eta (AU/mg Cru) Urinary REG3A (AU/mg Cru) Urinary FABP1 (AU/mg Cru) Urinary GM2AP (AU/mg Cru)
(a) Comparison between groups
Yes (n = 43) 5.64 ± 0.56 11.43 ± 1.63 18.27 ± 4.98 480.67 ± 131.11 0.03 ± 0.01 0.44 ± 0.11 2.23 ± 0.61 0.09 ± 0.05 0.07 ± 0.02 0.15 ± 0.06
No (n = 42) 6.39 ± 0.74 13.19 ± 2.04 21.43 ± 3.32 871.29 ± 156.91* 0.06 ± 0.02* 0.49 ± 0.11 2.89 ± 0.50 0.15 ± 0.04* 0.35 ± 0.13* 0.24 ± 0.06**
Parameter B SD Wald p value
(b) Logistic regression analysis (only GM2AP)
GM2AP 0.734 0.233 9.953 0.002
Constant − 1.747 0.600 8.482 0.004
Total percentage of success: 64.8%
Specificity: 69,4%
Sensitivity: 60,0%
(c) Logistic regression analysis (GM2AP + TCP1-eta)
GM2AP 0.757 0.244 9.663 0.002
TCP1-eta 0.559 0.243 5.307 0.021
Constant − 3.132 0.911 11.827 0.001
Total percentage of success: 76.1%
Specificity: 75.0%
Sensitivity: 77.1%

(a) Concentrations of the different biomarkers according to subsequent recovery pattern. Data are expressed as the mean ± SEM. *p < 0.05; **p < 0.01; versus “Recovery—Yes” group. (b) Results of the logistic regression performed with GM2AP. c) Results of the logistic regression performed with GM2AP + TCP1-eta. AU: arbitrary units; Cru: urinary creatinine; B: logistic regression coefficient; FABP1: fatty acid binding protein 1; GM2AP: GM2-activator protein; KIM-1: kidney injury molecule 1; NAG: N-acetyl-β-d-glucosaminidase; NGAL: Neutrophil gelatinase-associated lipocalin; REG3A: regenerating islet-derived 3 alpha; SD: Standard deviation; TCP1-eta: T-complex protein 1 eta; Wald: Wald statistic.